Rhodium(III) and iridium(III) complexes as anticancer agents
- 1 December 2012
- journal article
- review article
- Published by Elsevier BV in Inorganica Chimica Acta
- Vol. 393, 84-102
- https://doi.org/10.1016/j.ica.2012.06.046
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG)
This publication has 96 references indexed in Scilit:
- Cytotoxicity and cellular impact of dinuclear organoiridium DNA intercalators and nucleases with long rigid bridging ligandsDalton Transactions, 2012
- Cellular impact and selectivity of half-sandwich organorhodium(III) anticancer complexes and their organoiridium(III) and trichloridorhodium(III) counterpartsJBIC Journal of Biological Inorganic Chemistry, 2012
- Organometallic Iridium(III) Cyclopentadienyl Anticancer Complexes Containing C,N-Chelating LigandsOrganometallics, 2011
- Real-Time Monitoring of Cisplatin-Induced Cell DeathPLOS ONE, 2011
- Organometallic Half-Sandwich Iridium Anticancer ComplexesJournal of Medicinal Chemistry, 2011
- Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activityJBIC Journal of Biological Inorganic Chemistry, 2009
- Studies of the Mechanism of Action of Platinum(II) Complexes with Potent Cytotoxicity in Human Cancer CellsJournal of Medicinal Chemistry, 2009
- Molecular Recognition of DNA by Rigid [n]-Polynorbornane-Derived Bifunctional Intercalators: Synthesis and Evaluation of Their Binding PropertiesJournal of Medicinal Chemistry, 2007
- Determination of mitochondrial reactive oxygen species: methodological aspectsJournal of Cellular and Molecular Medicine, 2002
- Synthesis and DNA binding properties of bioorganometallic (η5-pentamethylcyclopentadienyl)iridium(iii) complexes of the type [(η5-C5Me5)Ir(Aa)(dppz)]n+ (dppz = dipyrido[3,2-a:2′,3′-c]phenazine, n = 1–3), with S-coordinated amino acids (Aa) or peptidesJ. Chem. Soc., Dalton Trans., 2002